Background: Previous studies of patients with invasive breast cancer examined, with mixed results, tumour location as a predictor of axillary lymph node metastasis. This study assessed whether tumour location in relation to the nipple impacts the presence of axillary lymph node metastasis at the time of diagnosis. Methods: A retrospective review was undertaken of the medical records and available imaging of 285 patients diagnosed with invasive breast cancer between January 2001 to June 2007 at Boston University Medical Center. The incidence of axillary lymph node metastasis was correlated with tumour location in relation to the posterior nipple line to control for variation in breast size. Bivariate analysis identified significant variables that were applied to a multiple logistic regression model. Results: Axillary lymph node metastasis was not significantly associated with tumour proximity to the nipple. In the multivariate logistic regression analysis, known prognostic factors for axillary metastasis, such as surgical size, lymphovascular invasion, and age of diagnosis, were significant, whereas breast density, palpability, and histologic grade were no longer significant. Conclusions: Our study found that there was no evidence that correlates intramammary tumour proximity to the nipple with the presence of axillary lymph node metastasis at diagnosis. However, known prognostic factors, such as lymphovascular invasion, surgical size, and younger age at diagnosis, are strong independent predictors for axillary lymph node involvement.
Axillary lymph node metastasis is the single most important parameter in determining breast cancer staging and treatment [1] . Specifically in women with small invasive breast carcinomas (less than 1 cm in size), the detection of axillary lymph node metastasis guides treatment regimens [2] . In the last decade, numerous studies correlated certain breast tumour characteristics, such as tumour size, histologic grade, palpability, and lymphovascular invasion, with a greater chance of axillary metastasis at the time of diagnosis [3e8] . In addition, many researchers have tried to determine if intramammary location of the breast tumour correlates to a higher rate of axillary metastasis and, therefore, a worse prognosis. Although some studies examined the breast 2-dimensionally by comparing medial with lateral locations, other studies tried to look at the breast 3-dimensionally comparing anterior with posterior regions [9e12] . In this retrospective analysis, we assessed tumour location by combining the 2-dimensional and 3-dimensional views of the breast by analysing tumour location on imaging relative to its relationship to the nipple. Because deep lymphatic channels of the breast anastomose at the subareolar plexus, which then drain to the axilla, we proposed that tumours close to the nipple should have a higher rate of axillary lymph node metastasis at diagnosis [13] .
Methods
This study was approved by the institutional review board at Boston University Medical Center. Between January 2001 and June 2007, 604 women diagnosed with invasive breast cancer were identified through a computerized database from the Clinical Data Warehouse at Boston University Medical Center. The database provided personal identifying information, medical record number, demographic details, and tumour stage. The information about clinical presentation and course, family history of breast cancer in first-degree relatives, diagnosis, histopathology, and radiologic studies was available from hospital records.
Of the population of 604 with the qualifying diagnosis of invasive cancer, 285 participants (47%) were eligible for the study. Eligibility criteria included any female of any age or ethnicity, histologically confirmed invasive breast cancer stage T1 or higher, available surgical axillary staging data from either sentinel lymph node biopsy or full axillary dissection, available mammogram before cancer treatment, and axillary staging before chemotherapy or radiation therapy. In addition, eligibility required there to be a single breast primary. A total of 319 patients (53%) were excluded from the study for the following reasons: radiologic examinations unavailable (165), axillary status unavailable (97), chemotherapy before axillary staging (30), multifocal cancer (10) , no surgery performed (7), unavailable medical records (7), Paget disease (2), and radiation before axillary staging (1) .
The mammographic studies were performed by using dedicated equipment (General Electric DMR, Milwaukee, WI; LoRad MIV, Hologic, Bedford, MA; Hologic Selenia, Bedford, MA). By using the cranial-caudal view of the breast, the location of the tumour was demarcated by a board-certified radiologist who specializes in breast imaging with filmscreen or digital hard copy images. The distance of the lesion from the nipple was measured in its relation to the posterior nipple line (from the surface of the nipple to the edge of the pectoralis muscle). Two relationships to the posterior nipple line were calculated by using a triangle drawn on the breast. One relationship was calculated of where the lesion fell parallel to the posterior nipple line, and the other relationship was where the tumour fell radially oriented to the posterior nipple line (Figure 1 ). These measurements allowed standardization, given the differences in breast size among patients. On available ultrasound images, a measurement was taken from the skin surface to the most superficial aspect of the tumour to determine the distance from the skin. The ultrasound studies were performed by using 2 different systems (ATL HDI or iU22 units; Philips, Amsterdam, The Netherlands), with either a 12.5 MHz or 17 MHz linear probe.
Clinical data from the eligible 285 patients with stage T1 or higher breast cancer were collected retrospectively from patient records. The clinical factors assessed were the following: age at diagnosis, history of use of oral contraceptives or hormone replacement therapy, palpability of primary tumour, family history of breast cancer, prior history of breast cancer, or a benign neoplasm. The radiologic factors assessed were the following: density of the breast (classified by using the 4 Breast Imaging Reporting and Data System [BI-RADS] density categories) [14] , and the distance from skin on ultrasound. Data about location of tumour were grouped into (1) 
Statistical Analysis
Initially, bivariate associations between outcome (axillary metastasis) and each clinical variable were assessed by using logistic regression. Candidate variables were then selected on the basis of the strength of bivariate association to construct a multivariable model. All statistically significant variables seen on the bivariate model were chosen for the multivariable model. Variables with significant bivariate associations were studied further. Specifically, by using a t test, we looked at the mean difference in the age of diagnosis vs dichotomized density of the breast. Associations are presented as odds ratios with 95% confidence intervals. All hypothesis tests were performed by using a significance level of .05, and all analyses were done with the R Statistical Package version 2.8.0 (2008; R Foundation, Vienna, Austria).
Results

Bivariate Analysis
The characteristics of the 285 cases are reported in Table 1 . Of the 285 study participants diagnosed with invasive breast carcinoma, 109 had axillary lymph node metastasis (38%). In the bivariate analysis, tumours that were node positive were significantly associated with palpability (P ¼ .0003), lymphovascular invasion (P ¼ .0001), histologic grade (P ¼ .004), tumour size (P ¼ .0001), density of the breast on mammography (P ¼ .02), and younger age at diagnosis (P ¼ .0001).
Nodal status was not significantly associated with tumour location in a 3-dimensional measurement with respect to the posterior nipple line. In addition, other parameters used to categorize tumour location 2-dimensionally by using quadrants or medial vs lateral regions of the breast were also not significantly associated with nodal metastasis. Furthermore, distance from the skin when using ultrasound measurement was not significantly associated with positive nodal status.
Multivariate Analysis
The results of the logistic regression model are reported in Table 2 . In the multivariable model lymphovascular invasion (P ¼ .001), younger age at diagnosis (P ¼ .01), and surgical size (P ¼ .01) continued to be significantly associated with axillary lymph node metastasis at the time of diagnosis. Palpability of the tumour (P ¼ .07), histologic grade (P ¼ .65), and density of the breast (P ¼ .91) were no longer significantly associated with positive nodes.
Discussion
Axillary lymph node metastasis remains the most predictive factor associated with prognosis for patients with operable breast cancer [15] . In the last decade, numerous studies tried to elucidate the association between breast tumour location and axillary lymph node metastasis. The research for the most part demonstrated that lymph node metastasis occurs more commonly with tumours located in the outer quadrants of the breast [1,6,9,14,16,17] . At the same time, results of many studies found a worse prognosis Boldface data denotes statistical significance (P < .05). a ¼ as delineated on Figure 1 for medially located tumours in the breast [11, 18, 19] . Many investigators purported that the association between outer quadrant breast tumours and increased axillary metastasis could be because the majority of breast tissue is found in the outer breast. In addition, the poorer prognosis of medially located tumours might be because metastatic spread to the internal mammary lymph node chain is unaccounted for in routine axillary lymph node dissection. Recently, researchers attempted to characterize tumour location association with axillary lymph node metastasis in novel ways. Cunningham et al [20] characterized the risk of axillary lymph node metastasis in terms of distance of the tumour from the skin by using ultrasound. They found that more superficial tumours were associated with axillary metastasis at diagnosis and postulated that tumour proximity to the lymphatic supply in the superficial dermal and subdermal layers likely explained their finding [20] . Likewise, Guth et al [12] performed a case-control study that compared axillary metastasis with tumours located in anterior vs posterior locations in the breast, finding anterior location of an invasive tumour that corresponded to a higher chance of axillary metastasis at diagnosis. Guth et al [12] proposed that anterior tumours in a 3-dimensional plane had higher nodal metastasis because of the rich cutaneous lymphatics of the superior, medial, and inferior breast that drain laterally to the axilla.
Although some researchers found that tumour skin and nipple involvement leads to higher rates of nodal metastasis, no studies have focused solely on the relationship of tumour location to the nipple [21] . Because of evidence that demonstrates that major lymphatic trunks from breast parenchyma connect directly with the subareolar plexus, we set out to determine if tumour location in proximity to the nipple had a higher rate of metastasis at diagnosis [13] . The analysis of our study revealed no association between axillary nodal metastasis at diagnosis and the 3-dimensional or 2-dimensional tumour location in relation to the nipple and subareolar lymphatic plexus.
Our attempt to 3-dimensionally characterize tumour proximity to the nipple failed to have any significant association most likely because of the inherent difficulty in ascribing a ratio in relation to the posterior nipple line for different breast sizes and shapes. Different techniques of mammography examinations, such as degrees of breast compression and tissue distribution, could have prevented a standardization of measurement. Moreover, our 3-dimensional assessment did not take into account the variability in the lymphatic networks among patients, and it may be that the exact location of the lymphatic network impacts whether axillary metastasis exists at diagnosis. Perhaps future studies that use lymphography can further assess the independent prognostic value of tumour location in relation to the lymphovascular network of the breast [22, 23] .
Moreover, our hypothesis that the convergence of lymphatic networks at the nipple makes periareolar tumour location a risk factor for axillary metastasis might be faulty. Perhaps tumour characteristics, not tumour location, portend breast cancer metastasis. At the same time, we did find some evidence of a relationship between tumour proximity to the nipple 2-dimensionally and axillary lymph node metastasis (P ¼ .16), although insignificant. The statistical insignificance of this relationship may be attributable to the small percentage of tumours found in the 2-dimensional periareolar region from our study cohort (n ¼ 16 [5%]). Further studies with a larger sample of women with periareolar tumours might be needed to further assess this relationship.
Our findings of no significant association between axillary metastasis and tumour location contradict recent literature in the last decade that postulates that tumour location can help predict axillary metastasis. Even when using novel ways to characterize tumour location by prescribing a 3-dimensional view of the breast or by ultrasound distance from the skin, we failed to find any significant association. Although not significant, 2-dimensional medial tumour location (P ¼ .31) was more likely to have axillary metastasis than lateral 2-dimensional medial location (P ¼ .94). This finding could lend further evidence to the body of research that finds medial tumour location associated with a worse prognosis and higher rates of metastasis [11] . Our study does not corroborate with studies in the literature that found outer quadrant tumours have a greater chance of axillary metastasis [9] .
Meanwhile, our data strongly support known tumour variables associated with axillary metastasis at diagnosis, such as surgical size, lymphovascular invasion, and younger age of diagnosis [3e8,24] . Although our bivariate model initially found palpability to be a significant variable associated with axillary metastasis, it was no longer significant in the multivariable model. On further examination, we found that 88% of palpable tumours had a surgical size >1.0 cm compared with just 55% of nonpalpable tumours with a surgical size >1.0 cm. This finding suggests that palpability was really just playing a proxy or surrogate marker for size of tumour. In addition, our bivariate model initially found greater breast density on mammography (BI-RADS categories 3 and 4) [14] to be associated with axillary nodal metastasis (P ¼ .02); however, it appears that this finding was confounded by age. On average, women with denser breasts are 9.7 years younger than women with more fatty breasts (P < .0001). The association between young age at diagnosis and nodal metastasis is represented in the multivariable model, which suggests that, in fact, age, not breast density, is the independent predictor for axillary metastasis at diagnosis.
In conclusion, we hope clinicians, when counseling patients before surgery, will rely on known factors of axillary metastasis, such as imaging size (to best approximate surgical size), lymphovascular invasion, and younger age of diagnosis, to guide discussions about prognosis. Furthermore, clinicians can advise patients with these known tumour characteristics that they more likely will require a complete axillary dissection because of a higher likelihood of positivity with sentinel lymph node biopsy. Because of our results and the mixed data in the last 2 decades regarding tumour location and its relationship to axillary metastasis, tumour location does not appear to be a helpful predictor of axillary metastasis at the time of diagnosis.
